Review: Inhaled insulin provides better glycemic control than oral hypoglycemic agents but not better than subcutaneous insulin

March 2007
ACP Journal Club;Mar/Apr2007, Vol. 146 Issue 2, p38
Academic Journal
The article presents a study which analyzes that inhaled insulin provides better glycemic control than oral hypoglycemic agents but not better than subcutaneous (SC) insulin. In the study, inhaled insulin did not reduce HbA[sub 1c], level as much as SC insulin in patients with type 1 and type 2 diabetes but did reduce it more than oral agents in patients with type 2 diabetes.


Related Articles

  • Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes. DEFRONZO, RALPH A.; ELDOR, ROY; ABDUL-GHANI, MUHAMMAD // Diabetes Care;Aug2013 Supplement, Vol. 36 Issue S2, pS127 

    The article discusses a study on pathophysiologic approach to treatment for type 2 diabetes mellitus (T2DM). This approach uses initial combination therapy with agents known to correct established pathophysiologic defects in T2DM. It is stated that in this approach, the choice of anti-diabetes...

  • VITAL: Paricalcitol reduced renal, CV risks in patients with diabetic nephropathy.  // Endocrine Today;Jan2011, Vol. 9 Issue 1, p24 

    This article discusses the effectiveness of the combination of paricalcitol and renin-angiotension-aldosterone system inhibition in lowering residual renal risk for patients with type 2 diabetes.

  • Type 2 diabetes in adults. Martyn, Annette // Nursing Standard;4/5/2006, Vol. 20 Issue 30, p67 

    The article reflects on how a British nurse gained the confidence to discuss medicine regimen with her type 2 diabetes patients through an article by H.M. Lakka and colleagues. The article is relevant to the nurse's practice because she is undertaking a post-registration course in diabetes. The...

  • Strategies for insulin impairment. R.M.D. // Cortlandt Forum;2/25/96, Vol. 9 Issue 2, p124 

    Responds to queries on efficacy of prescribing hypoglycemic agents among non-insulin dependent diabetics. Insulin levels; Recommendations for alternative medication regimen including exercise and proper diet.

  • Higher liver transaminase levels and oral hypoglycemic drug therapy failure in patients with type 2 diabetes: is iron the missing link? Mascitelli, Luca; Goldstein, Mark // Acta Diabetologica;Dec2011, Vol. 48 Issue 4, p355 

    A letter to the editor is presented in response to the article "Transaminase levels in the upper normal range are associated with oral hypoglycemic drug therapy failure in patients with type 2 diabetes," by C. Irace and colleagues in the 2011 issue.

  • Notice of redundant publication. Porta, Massimo; Pozza, Guido; Lauro, Renato // Acta Diabetologica;Apr2014, Vol. 51 Issue 2, p313 

    A correction to the article "A nomogram to estimate the proportion of patients at haemoglobin A1c target\7 percent with noninsulin antidiabetic drugs in type 2 diabetes: a systematic review of 137 randomized controlled trials" that was published in the January 28, 2012 issue is presented.

  • Screening for Silent Coronary Heart Disease in Type 2 Diabetes. Kharlip, Julia; Naglieri, Rosalie; Mitchell, Braxton D.; Ryan, Kathleen A.; Donner, Thomas W. // Diabetes Care;Mar2006, Vol. 29 Issue 3, p692 

    Presents a study which determined the proportion of patients in a clinical setting with type 2 diabetes. Research design and methods used; Statistical analysis of patients' data; Risk factor profile of patients.

  • The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study. Mahrooz, Abdolkarim; Parsanasab, Hassan; Hashemi-Soteh, Mohammad; Kashi, Zahra; Bahar, Adele; Alizadeh, Ahad; Mozayeni, Maliheh // Clinical & Experimental Medicine;May2015, Vol. 15 Issue 2, p159 

    A major predicament in certain users of metformin, which is one of the most commonly used antihyperglycemic agents for type 2 diabetes (T2DM) treatment, is the lack of appropriate response to the drug. We evaluated the role of metformin response and OCT1 (organic cation transporter1) Met420del...

  • Diabetes: Kicking off the insulin cascade. Jackson, Catherine // Nature;12/14/2006, Vol. 444 Issue 7121, p833 

    The article discusses the inhibition of the insulin-signaling pathway. It has been noted that the inhibition of the insulin-signaling pathway leads to insulin resistance, an early step in the development of type 2 diabetes. Many of the vital cellular processes that were vital for human health...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics